Publications by authors named "Jin Kook Kang"

Background: While left ventricular (LV) venting reduces LV distension in cardiogenic shock patients on venoarterial extracorporeal membrane oxygenation (VA-ECMO), it may also amplify risk of acute brain injury (ABI). We investigated the hypothesis that LV venting is associated with increased risk of ABI. We also compared ABI risk of the two most common LV venting strategies, percutaneous microaxial flow pump (mAFP) and intra-aortic balloon pump (IABP).

View Article and Find Full Text PDF

Objective: Annuloplasty is the most common strategy for repair of functional tricuspid regurgitation (FTR) but is not effective in patients with massive/torrential FTR or leaflet tethering. To address the deficits of tricuspid annuloplasty, TRicuspid Anterior and Posterior Patch (TRAPP) repair was developed, which is a pericardial patch augmentation of the anterior and posterior leaflets.

Methods: To test this repair, a previously validated ex vivo model in an explanted porcine heart was used, wherein annular and leaflet geometry were evaluated using a 3-dimensional structured light scanner at 4 time points: (1) baseline, (2) induction of FTR, (3) annuloplasty repair, and (4) patch repair.

View Article and Find Full Text PDF

Background: Failure to rescue (FTR) is mortality after at least 1 postoperative complication. We investigated the impact of nighttime intensivist staffing and FTR after cardiac surgery.

Methods: We included patients who underwent cardiac surgery to examine FTR, defined as mortality in those who experienced a Society of Thoracic Surgeons-defined major complication.

View Article and Find Full Text PDF
Article Synopsis
  • Conventional MRI isn't compatible with ECMO systems, but ultra-low-field portable MRI (ULF-pMRI) might be a safer alternative, though its safety with ECMO is uncertain.
  • The study tested various ECMO cannulas, both in lab settings and on pigs, to evaluate the impact of ULF-pMRI on cannula displacement and heating, as well as pump functionality.
  • Results showed that ULF-pMRI poses minimal risk to ECMO equipment, maintaining stable conditions for both the cannulas and pumps, suggesting it's a viable option for brain imaging in patients on ECMO.
View Article and Find Full Text PDF

Background: Early detection of acute brain injury (ABI) at the bedside is critical in improving survival for patients with extracorporeal membrane oxygenation (ECMO) support. We aimed to examine the safety of ultra-low-field (ULF; 0.064-T) portable magnetic resonance imaging (pMRI) in patients undergoing ECMO and to investigate the ABI frequency and types with ULF-pMRI.

View Article and Find Full Text PDF
Article Synopsis
  • - Low pulse pressure (PP) during venoarterial-extracorporeal membrane oxygenation (VA-ECMO) is linked to cardiac dysfunction and increased risk of acute brain injury (ABI), with a specific focus on central nervous system (CNS) issues.
  • - An analysis of 9,807 patients showed that 15% had a low PP (≤10 mm Hg), and these patients experienced ABI more frequently (15% vs. 11%) compared to those with higher PP.
  • - Low PP was independently associated with higher chances of CNS ischemia and brain death, highlighting the importance of monitoring pulse pressure in patients receiving peripheral VA-ECMO.
View Article and Find Full Text PDF
Article Synopsis
  • Neuron-specific enolase (NSE) is a biomarker that has been used to predict neurologic outcomes after cardiac arrest, and this study specifically evaluates its effectiveness in patients undergoing extracorporeal cardiopulmonary resuscitation (ECPR).
  • The study included 47 adult ECPR patients, revealing that 46.8% experienced poor neurologic outcomes and 25.5% had abnormal brain CT findings.
  • NSE levels measured 72 hours after ECPR were found to be the most predictive of poor outcomes and 30-day mortality, with cutoff values indicating significant predictive power.
View Article and Find Full Text PDF
Article Synopsis
  • Over 1.2 million pulmonary artery catheters (PACs) are used annually in cardiac patients in the U.S., but these devices can't be used during traditional MRI scans, prompting research into their safety in this imaging technique.
  • Two experiments tested the safety of PACs in MRI settings, ensuring that the electromagnetic field exposure stayed within the FDA's safety limits while assessing potential adverse effects.
  • The study showed that low-field MRI was safe and effective for patients with PACs, allowing for quality imaging to detect acute brain injuries that might be missed with standard CT scans.
View Article and Find Full Text PDF

Early detection of acute brain injury (ABI) is critical to intensive care unit (ICU) patient management and intervention to decrease major complications. Head CT (HCT) is the standard of care for the assessment of ABI in ICU patients; however, it has limited sensitivity compared to MRI. We retrospectively compared the ability of ultra-low-field portable MR (ULF-pMR) and head HCT, acquired within 24 h of each other, to detect ABI in ICU patients supported on extracorporeal membrane oxygenation (ECMO).

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the safety and effectiveness of ultra-low-field portable MRI (ULF-pMRI) for detecting acute brain injuries (ABI) in patients on extracorporeal membrane oxygenation (ECMO) support.* -
  • Conducted at two academic centers, the study involved 50 patients, with successful imaging and a low incidence of adverse events; ABI was found in 44% of patients, mostly ischemic strokes.* -
  • ULF-pMRI proved to be a safe and potentially more sensitive method for detecting ischemic brain injuries compared to traditional head CT scans, indicating its usefulness in clinical settings and further research.*
View Article and Find Full Text PDF

Background And Objectives: Despite the common occurrence of neurologic complications during extracorporeal membrane oxygenation (ECMO) support, data on long-term neuropsychiatric, neurocognitive, and functional outcomes are sparse. We aimed to determine the prevalence of long-term neuropsychiatric symptoms, neurocognitive and functional impairment, and favorable neurologic outcomes in adult patients who receive ECMO.

Methods: PubMed, Embase, Cochrane, Web of Science, and Scopus were searched for text related to ECMO and neuropsychiatric, neurocognitive, and functional outcomes from inception to May 3, 2023.

View Article and Find Full Text PDF
Article Synopsis
  • Patients undergoing postcardiotomy V-A-ECMO have a high risk of early mortality, with a 66.7% in-hospital mortality rate found in the analysis of 1269 patients across 25 hospitals.
  • The study utilized a systematic review and methods like propensity score matching to identify performance differences among hospitals, revealing that some hospitals had significantly higher mortality rates than others.
  • The research indicates that lower annual volumes of V-A-ECMO procedures may lead to worse outcomes, and it highlights the potential for improvement in many hospitals' results for this treatment.
View Article and Find Full Text PDF

Background: Low pulse pressure (PP) in venoarterial-extracorporeal membrane oxygenation (VA-ECMO) is a marker of cardiac dysfunction and has been associated with acute brain injury (ABI) as continuous-flow centrifugal pump may lead to endothelial dysregulation.

Methods: We retrospectively analyzed adults (≥18 years) on "peripheral" VA-ECMO support for cardiogenic shock in the Extracorporeal Life Support Organization Registry (1/2018-7/2023). Cubic splines were used to establish a threshold (PP≤10 mmHg at 24 hours of ECMO support) for "early low" PP.

View Article and Find Full Text PDF

Objectives: Extracorporeal cardiopulmonary resuscitation (ECPR) serves as a lifesaving intervention for patients experiencing refractory cardiac arrest. With its expanding usage, there is a burgeoning focus on improving patient outcomes through optimal management in the acute phase after cannulation. This review explores systematic post-cardiac arrest management strategies, associated complications, and prognostication in ECPR patients.

View Article and Find Full Text PDF

Background: Despite the high prevalence of neurological complications and mortality associated with extracorporeal cardiopulmonary resuscitation (ECPR), neurologically-focused animal models are scarce. Our objective is to review current ECPR models investigating neurological outcomes and identify key elements for a recommended model.

Methods: We searched PubMed and four other engines for animal ECPR studies examining neurological outcomes.

View Article and Find Full Text PDF

Extracorporeal membrane oxygenation (ECMO), in conjunction with its life-saving benefits, carries a significant risk of acute brain injury (ABI). Hypoxic-ischemic brain injury (HIBI) is one of the most common types of ABI in ECMO patients. Various risk factors, such as history of hypertension, high day 1 lactate level, low pH, cannulation technique, large peri-cannulation PaCO drop (∆PaCO), and early low pulse pressure, have been associated with the development of HIBI in ECMO patients.

View Article and Find Full Text PDF

Objective: Atrial fibrillation (AF), if left untreated, is associated with increased intermediate and long-term morbidity/mortality. Surgical treatment for AF is lacking standardization in patient selection and lesion set, despite clear support from multi-society guidelines. The aim of this study was to analyze a statewide cardiac surgery registry to establish whether or not there is an association between center volume and type of index procedure with performance of surgical ablation (SA) for AF, the lesion set chosen, and ablation technology used.

View Article and Find Full Text PDF
Article Synopsis
  • Postcardiotomy veno-arterial extracorporeal membrane oxygenation (V-A-ECMO) has a high mortality rate, and determining which patients are at the greatest risk for death is challenging, making clinical judgment essential for initiating the procedure.
  • A systematic review analyzed data from 1269 patients across 10 studies, revealing that higher arterial lactate levels at the start of V-A-ECMO correlate with increased in-hospital mortality rates and a significant cut-off level of 6.8 mmol/L for predicting outcomes.
  • The findings suggest that monitoring arterial lactate levels may aid clinicians in making more informed decisions on when to start V-A-ECMO, especially in older patients with elevated lactate levels.
View Article and Find Full Text PDF

Background: It is unclear whether peripheral arterial cannulation is superior to central arterial cannulation for postcardiotomy veno-arterial extracorporeal membrane oxygenation (VA-ECMO).

Methods: A systematic review was conducted using PubMed, Scopus, and Google Scholar to identify studies on postcardiotomy VA-ECMO for the present individual patient data (IPD) meta-analysis. Analysis was performed according to the intention-to-treat principle.

View Article and Find Full Text PDF

Lutein has been used as a dietary supplement for the treatment of eye diseases, especially age-related macular degeneration. For oral formulations, we investigated lutein stability in artificial set-ups mimicking different physiological conditions and found that lutein was degraded over time under acidic conditions. To enhance the stability of lutein upon oral intake, we developed enteric-coated lutein solid dispersions (SD) by applying a polymer, hydroxypropyl methylcellulose acetate succinate (HPMCAS-LF), through a solvent-controlled precipitation method.

View Article and Find Full Text PDF

The development of an oral formulation that ensures increased bioavailability of drugs is a great challenge for pharmaceutical scientists. Among many oral formulation systems, a drug delivery system employing superporous networks was developed to provide a prolonged gastro-retention time as well as improved bioavailability of drugs with a narrow absorption window in the gastrointestinal tract. Superporous networks (SPNs) were prepared from chitosan by crosslinking with glyoxal and poly(vinyl alcohol) (PVA).

View Article and Find Full Text PDF

Over the past few decades, hyperthermia therapy (HTT) has become one of the most promising strategies to treat cancer. HTT has been applied with nanotechnology to overcome drawbacks such as non-selectivity and invasiveness and to maximize therapeutic efficacy. The high temperature of HTT induces protein denaturation that leads to apoptosis or necrosis.

View Article and Find Full Text PDF

Nanotechnology-based photo-chemo combination therapy has been extensively investigated to improve therapeutic outcomes in anticancer treatment. Specifically, with the help of a singlet oxygen generated by the photosensitizer, the endocytosed nanoparticles are allowed to escape from the endosomal compartment, which is currently an obstacle in nanotechnology-based anticancer therapy. In this study, a liposomal complex system (Lipo (Pep, Ce6)), composed of a chlorin e6-conjugated di-block copolymer (PEG-PLL(--Ce6)) and a D-(KLAKLAK) peptide loading liposome (Lipo (Pep)), was developed and evaluated for its anticancer activity.

View Article and Find Full Text PDF

Docetaxel (DTX)-loaded polymeric micelles (DTBM) were formulated using the triblock copolymer, poly(ethylene glycol)-polylactide-poly(ethylene glycol) (PEG-PLA-PEG), to comprehensively study their pharmaceutical application as anticancer nanomedicine. DTBM showed a stable formulation of anticancer nanomedicine that could be reconstituted after lyophilization (DTBM-R) in the presence of PEG 2000 and D-mannitol (Man) as surfactant and protectant, respectively. DTBM-R showed a particle size less than 150 nm and greater than 90% of DTX recovery after reconstitution.

View Article and Find Full Text PDF